Drugs

SyntheticMR, a front-runner in the field of quantitative imaging software, recently revealed that its SyMRI 15 solution has been granted 510(k) approval by the US Food and Drug Administration (FDA), allowing it to replace traditional diagnostic images. The SyMRI 15 […]

The Max Foundation, an international nonprofit focused on advancing health equity, is set to expand its partnership with Novartis to include the innovative treatment Fabhalta (iptacopan) for paroxysmal nocturnal hemoglobinuria (PNH) in low-resource regions. This development aims to provide cutting-edge

Research supported by the National Institutes of Health suggests that a lone alteration in the protein on the exterior of the highly pathogenic H5N1 avian influenza strain, which is now present in US dairy cattle, may enhance its transmission to

Aristocrat Media, renowned for championing industry excellence, is gearing up to host its eagerly awaited 2nd Future Health Conclave & Awards 2024 on December 21 at Mumbai’s Ginger Hotel. This event is set to gather over 100 influential leaders, forward-thinking

BioArctic AB (publ), a Swedish biotech firm focused on research, has revealed the commencement of patient dosing with their experimental drug, exidavnemab, in the phase 2a EXIST trial dedicated to those battling Parkinson’s disease. This drug is a monoclonal antibody

**Ariceum Therapeutics** (Ariceum), a private biotech company specializing in radiopharmaceutical development for diagnosing and treating challenging cancer types, alongside **Eckert & Ziegler**, a leading global distributor of medical isotopes for various applications, have officially entered into a worldwide supply pact

In an extensive analysis of the urgent matters confronting India’s pharmaceutical export sector, the Federation of Pharma Merchant Exporters (FPME) has pinpointed pivotal issues that demand swift action. These reforms are essential to streamline business operations and bolster India’s standing

Expressing apprehensions about the recent guidelines issued by the National Commission for Indian System of Medicines (NCISM), which pertain to hiring new faculty and acquiring contemporary equipment in existing Ayurveda colleges, the Kerala ISM College Management Association (KISMA) has advocated

The Production-Linked Incentive (PLI) initiative aimed at enhancing domestic production of medical devices, launched by the central administration to stimulate local manufacturing and attract significant investments in this sector, has achieved nearly 78% of its pledged investment thus far. The

Dr. Neetu Mittal, a senior consultant specializing in infection control and microbiology at Sarvodaya Hospital in Faridabad, has issued a warning regarding the growing threat of antimicrobial resistance (AMR). She identifies significant problems in antibiotic regulation and the failure to